Constructive Bio
Pre-clinicalCambridge UK biotech using Syn61 E. coli and 300+ non-canonical amino acids to manufacture peptide therapeutics via fermentation.
Founded
2021
Focus
Synthetic BiologyDrug Delivery
About
Cambridge UK biotech using Syn61 E. coli and 300+ non-canonical amino acids to manufacture peptide therapeutics via fermentation.
Funding History
1Total raised: $15M
Seed$15MAhren Innovation CapitalJun 15, 2022
Company Info
TypePrivate
Founded2021
LocationCambridge, United Kingdom
StagePre-clinical
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile